SCHEMBL2809872

SCHEMBL2809872

CC(C)Oc1ccc(Nc2ccc(CNC(=O)C3(N)CC3)cc2)c(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.40
NR1H4 Q96RI1 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
NAMPT P43490 1/20 0.38
RXFP1 Q9HBX9 3/20 0.37
AKT2 P31751 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 4/20 0.36
P2RX3 P56373 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
EPHX2 P34913 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809865 0.89 TP53 (0.39) TP53NR1H4NPC1RAB9ANAMPT
SCHEMBL2808315 0.88 NPC1 (0.41) NR1H4NPC1RAB9ANAMPTAKT2
Hydrochloric Acid SCHEMBL2805730 0.86 AKT2 (0.38) TP53AKT2EPHX2CA1CA2
SCHEMBL185133 0.83 CNR2 (0.41) NPC1RAB9AAKT2POLBALDH1A1
SCHEMBL2805808 0.80 BDKRB1 (0.48) TP53NR1H4NAMPTPOLBMAPT
SCHEMBL184945 0.80 MT-CO2 (0.43) NPC1RAB9ANAMPTAKT2POLB
SCHEMBL185509 0.80 P2RX3 (0.43) TP53POLBMAPTP2RX3ALDH1A1
SCHEMBL2782059 0.79 BDKRB1 (0.39) TP53NR1H4NPC1RAB9ANAMPT
SCHEMBL13160172 0.78 TP53 (0.33) TP53NR1H4NPC1RAB9ANAMPT
SCHEMBL2778630 0.77 NPC1 (0.40) NR1H4NPC1RAB9ANAMPTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 TP53 2836/4885NR1H4 116/4885NPC1 926/4885
US-20100240669-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 TP53 2836/4885NR1H4 116/4885NPC1 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.